Labcorp Holdings (LH) Receivables (2009 - 2026)

Labcorp Holdings has disclosed Receivables across 18 years of filings, most recently posting $2.5 billion for Q2 2026.

• In Q2 2026, Receivables rose 9.72% year-over-year to $2.5 billion; the TTM figure through Jun 2026 stood at $2.5 billion (up 9.72% YoY), while the FY2025 annual figure was $2.3 billion, up 7.81% from the prior year.
• Receivables came in at $2.5 billion for Q2 2026 at Labcorp Holdings, up from $2.5 billion in the prior quarter.
• In the past five years, Receivables ranged from a high of $3.0 billion in Q1 2023 to a low of $2.0 billion in Q4 2022.
• Average Receivables over 5 years is $2.4 billion, with a median of $2.3 billion recorded in 2025.
• Year-over-year, Receivables plunged 32.94% in 2022 and rose 9.98% in 2024.
• Over 5 years, Receivables stood at $2.0 billion in 2022, then increased by 5.08% to $2.1 billion in 2023, then retreated by 0.08% to $2.1 billion in 2024, then increased by 7.81% to $2.3 billion in 2025, then gained by 10.8% to $2.5 billion in 2026.
• Per Business Quant data, the three most recent Receivables figures were $2.5 billion in Q2 2026, $2.5 billion in Q1 2026, and $2.3 billion in Q4 2025.